1. Home
  2. SI vs CERS Comparison

SI vs CERS Comparison

Compare SI & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SI
  • CERS
  • Stock Information
  • Founded
  • SI 2009
  • CERS 1991
  • Country
  • SI United States
  • CERS United States
  • Employees
  • SI N/A
  • CERS N/A
  • Industry
  • SI Medical/Dental Instruments
  • CERS EDP Services
  • Sector
  • SI Health Care
  • CERS Technology
  • Exchange
  • SI Nasdaq
  • CERS Nasdaq
  • Market Cap
  • SI 248.2M
  • CERS 276.0M
  • IPO Year
  • SI 2025
  • CERS 1997
  • Fundamental
  • Price
  • SI $11.72
  • CERS $1.47
  • Analyst Decision
  • SI Strong Buy
  • CERS Buy
  • Analyst Count
  • SI 5
  • CERS 1
  • Target Price
  • SI $19.60
  • CERS $4.00
  • AVG Volume (30 Days)
  • SI 50.3K
  • CERS 1.2M
  • Earning Date
  • SI 11-11-2025
  • CERS 11-06-2025
  • Dividend Yield
  • SI N/A
  • CERS N/A
  • EPS Growth
  • SI N/A
  • CERS N/A
  • EPS
  • SI N/A
  • CERS N/A
  • Revenue
  • SI $37,324,000.00
  • CERS $192,510,000.00
  • Revenue This Year
  • SI $40.62
  • CERS $19.07
  • Revenue Next Year
  • SI $33.40
  • CERS $12.03
  • P/E Ratio
  • SI N/A
  • CERS N/A
  • Revenue Growth
  • SI 64.07
  • CERS 13.25
  • 52 Week Low
  • SI $11.51
  • CERS $1.12
  • 52 Week High
  • SI $17.94
  • CERS $2.24
  • Technical
  • Relative Strength Index (RSI)
  • SI N/A
  • CERS 47.25
  • Support Level
  • SI N/A
  • CERS $1.48
  • Resistance Level
  • SI N/A
  • CERS $1.55
  • Average True Range (ATR)
  • SI 0.00
  • CERS 0.08
  • MACD
  • SI 0.00
  • CERS -0.02
  • Stochastic Oscillator
  • SI 0.00
  • CERS 25.00

About SI Shoulder Innovations Inc. Common Stock

Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: